To determine if SIK2 affects cancer cell motility, siRNA transfection was used to deplete SIK2 in ovarian cancer cell lines (SKOV3 and OVCAR8) and breast cancer cell lines (MDA‐MB‐231 and Hs578t). Here, SIK2 is linked to cancer.